Annex
United Kingdom
In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘closantel’ is replaced by the following:
Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification ‘Closantel Closantel Bovine 1 000 μg/kg
3 000 μg/kg
1 000 μg/kg
3 000 μg/kg
45 μg/kg
Muscle
Fat
Liver
Kidney
Milk
NO ENTRY Antiparasitic agents/Agents against endoparasites’ Ovine 1 500 μg/kg
2 000 μg/kg
1 500 μg/kg
5 000 μg/kg
45 μg/kg
Muscle
Fat
Liver
Kidney
Milk